GPCR/G protein
Research Areas
- Neuropeptide FF/AF Receptors(54)
- Neuropeptide S Receptor(3)
- GPBA Receptor(5)
- Trace Amine 1 Receptor(2)
- GPCR protein(1)
- FFAR3(1)
- Formyl Peptide Receptors(11)
- 5-HT Receptor(431)
- Acetylcholine(28)
- Adenosine Deaminase(10)
- Adenosine Receptor(143)
- Adenosine Kinase(5)
- Adiponectin Receptor(3)
- Adrenergic Receptor(450)
- Adrenergic Transporters(5)
- Apelin Receptor(9)
- Angiotensin Receptor(118)
- Bombesin Receptors(26)
- Bradykinin Receptors(30)
- Calcitonin and Related Receptors(10)
- Cannabinoid Receptor(121)
- Calcimimetic Agent(2)
- CaSR(28)
- CCK1 Receptors(7)
- CCK2 Receptors(7)
- CCR(98)
- Chemokine Receptors(23)
- CRF1 Receptors(10)
- CRF2 Receptors(3)
- CXCR(108)
- CysLT1 receptor(1)
- Endothelin Receptor(54)
- EP1 Receptor(2)
- EP4 Receptor(2)
- ERRγ(1)
- ETA Receptors(5)
- ETB Receptors(5)
- Free Fatty Acid Receptors(16)
- Galanin Receptors(11)
- Ghrelin Receptors(11)
- GHSR(20)
- GIP Receptor(5)
- Glucagon Receptor(54)
- Glucocorticoid Receptor(103)
- GLUT1(1)
- Gonadotropin-Releasing Hormone Receptors(3)
- GPCR19(12)
- GPR109A(4)
- GPR119(11)
- GPR120(9)
- GPR35(10)
- GPR44(1)
- GPR55(11)
- Hydroxycarboxylic Acid Receptors(5)
- Leukotriene Receptor(57)
- LPA Receptor(12)
- LPL Receptor(64)
- LTD4 Receptor(1)
- mGluR (126)
- Melanin-concentrating Hormone Receptors(7)
- Melanocortin (MC) Receptors(62)
- Melatonin Receptors(23)
- Motilin Receptor(7)
- MT Receptor(1)
- Non-selective CRF(7)
- Neurotensin Receptors(26)
- NK2 Receptors(7)
- NK3 Receptor(5)
- NOP Receptor(20)
- NPY Receptors(26)
- Orexin(3)
- Orphan 7-TM Receptors(6)
- OX Receptor(58)
- Oxytocin Receptors(22)
- P2Y Receptor(66)
- PACAP Receptors(7)
- PAF Receptors(7)
- Peptide Receptors(14)
- PGD2 Receptor(1)
- Prostaglandin Receptor(179)
- Prostanoid Receptors(25)
- Protease-Activated Receptors(9)
- RGS(2)
- S1P receptor(8)
- Secretin Receptors(1)
- Sensory Neuron-Specific Receptors(1)
- Somatostatin Receptor(47)
- Sigma Receptor(62)
- Vasopressin Receptor(34)
- 17,20-lyase(4)
- Ras(180)
- Urotensin-II Receptor(10)
- VIP Receptors(6)
- EBI2/GPR183(7)
- TSH Receptor(12)
- NK Receptor(1)
- GPR81(1)
- C3aR(1)
- CysLT2 receptor(1)
- S1P receptor inhibitor(22)
- CCKB(1)
- FFAR1 (GPR40)(20)
- GPR84(11)
- Neuromedin U Receptors(2)
- Kisspeptin Receptor(8)
- CRFR(27)
- RGS Protein(5)
- Urotensin Receptor(7)
- Cholecystokinin Receptor(29)
- GPR139(4)
- mAChR(200)
- MCHR1 (GPR24)(17)
- Neurokinin Receptor(78)
- cGMP(27)
- GRK(5)
- GPR88(3)
- Amylin Receptor(9)
- Arrestin(10)
- Mas-related G-protein-coupled Receptor (MRGPR)(10)
- GCGR(13)
- GLP Receptor(27)
- Succinate Receptor 1(1)
- PTHR(3)
- Protease Activated Receptor (PAR)(6)
- Free Fatty Acid Receptor(5)
- Formyl Peptide Receptor (FPR)(7)
- Hydroxycarboxylic Acid Receptor (HCAR)(2)
- RXFP Receptor(3)
- Adhesion G Protein-coupled Receptors (AGPCRs)(1)
- Taste Receptor(1)
- GPR52(1)
Products Related to GPCR/G protein(3732)
- GC68618ACT-1004-1239CAS: 2178049-58-4Purity: >99.00%
ACT-1004-1239는 유효하고 선택적이며 경구용 CXCR7 억제제로, IC50 값은 3.2 nM입니다.
- GC68619ACT-660602CAS: 1646267-59-5Purity: >99.00%
ACT-660602는 경구 흡수 활성을 가진 유도체 수용 체 CXCR3 억제제로, IC50는 204 nM입니다. ACT-660602는 T 세포 이동을 억제하며 급성 폐손상 모델에서 현저한 효과를 나타냅니다. ACT-660602는 자가면역 질환 연구에 사용될 수 있습니다.
| Catalog No. | Product Name | CAS No. | Purity | Structure |
|---|---|---|---|---|
| GC67989 | (S)-Mirtazapine | 61337-87-9 | >98.00% | |
| GC68004 | GDC-6036-NH | 2417918-80-8 | >98.00% | |
| GC68040 | MSX-127 | 6616-56-4 | >98.00% | |
| GC68210 | (+)-Norfenfluramine | 19036-73-8 | >98.00% | |
| GC68316 | Loteprednol Etabonate-d5 | 2026643-11-6 | >98.00% | |
| GC68320 | Aprocitentan D4 | - | >98.00% | |
| GC68326 | Ipratropium-d3 bromide | - | >98.00% | |
| GC68327 | 4-Hydroxyatomoxetine-d3 | 1217686-14-0 | >98.00% | |
| GC68328 | 3-Hydroxy agomelatine-d3 | 1079774-23-4 | >98.00% | |
| GC68331 | Ramelteon metabolite M-II-d3 | 1246812-22-5 | >98.00% | |
| GC68335 | N-Demethyl MK-6884 | 2102194-36-3 | >98.00% | |
| GC68349 | Ifetroban sodium | 156715-37-6 | >98.00% | |
| GC68364 | Flibanserin-d4-1 | 2122830-91-3 | >98.00% | |
| GC68381 | L-Glutamine-1-13C | 159663-16-8 | >98.00% | |
| GC68407 | Phenylethanolamine A-d3 | 2507994-61-6 | >98.00% | |
| GC68410 | (S)-Mirtazapine-d3 | - | >99.00% | |
| GC68418 | Clenbuterol-d9 | 129138-58-5 | >98.00% | |
| GC68419 | Prasugrel-d3 | 1127253-02-4 | >98.00% | |
| GC68424 | Fingolimod-d4 hydrochloride | 1346604-90-7 | >98.00% | |
| GC68435 | Clazosentan | 180384-56-9 | >98.00% | |
| GC68442 | L-Glutamine-15N-1 | 59681-32-2 | >98.00% | |
| GC68469 | CID1231538 | 354126-20-8 | >99.00% | |
| GC68618 | ACT-1004-1239 | 2178049-58-4 | >99.00% | |
ACT-1004-1239는 유효하고 선택적이며 경구용 CXCR7 억제제로, IC50 값은 3.2 nM입니다. | ||||
| GC68619 | ACT-660602 | 1646267-59-5 | >99.00% | |
ACT-660602는 경구 흡수 활성을 가진 유도체 수용 체 CXCR3 억제제로, IC50는 204 nM입니다. ACT-660602는 T 세포 이동을 억제하며 급성 폐손상 모델에서 현저한 효과를 나타냅니다. ACT-660602는 자가면역 질환 연구에 사용될 수 있습니다. | ||||